UnitedHealth paid ransom to bad actors, says patient data was compromised in Change Healthcare cyberattack

UnitedHealth paid ransom to bad actors, says patient data was compromised in Change Healthcare cyberattack


Omar Marques | Lightrocket | Getty Images

UnitedHealth Group on Monday said it paid a ransom to cyber threat actors to try and protect patient data, following the February cyberattack on its subsidiary Change Healthcare. The company also confirmed that files containing personal information were compromised in the breach.

“This attack was conducted by malicious threat actors, and we continue to work with the law enforcement and multiple leading cyber security firms during our investigation,” UnitedHealth told CNBC in a statement. “A ransom was paid as part of the company’s commitment to do all it could to protect patient data from disclosure.”

The company did not specify the ransom payment amount.

UnitedHealth, which has more than 152 million customers, said it has also determined that the cyber threat actors accessed files containing protected health information and personally identifiable information, according to a release Monday. The files “could cover a substantial proportion of people in America,” the release said.

Change Healthcare offers payment and revenue cycle management tools. The company facilitates more than 15 billion transactions annually, and one in every three patient records passes through its systems. This means even patients who are not UnitedHealth customers could have been impacted by the attack.

UnitedHealth said in the release that 22 screenshots, allegedly of the compromised files, have been uploaded to the dark web. The company said no other data has been published, and it has not seen evidence that doctors’ charts or full medical histories were accessed in the breach.

“We know this attack has caused concern and been disruptive for consumers and providers and we are committed to doing everything possible to help and provide support to anyone who may need it,” UnitedHealth CEO Andrew Witty said in the release.

UnitedHealth said that concerned patients can visit a dedicated website for access to resources. The company has launched a call center that will offer free identity theft protections and credit monitoring for two years, the release said.

The call center will not be able to offer any details about individual data impact given the “ongoing nature and complexity of the data review,” UnitedHealth said.



Source

Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo Nordisk
Health

Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo Nordisk

US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on Nov. 6, 2025. Andrew Caballero-Reynolds | AFP | Getty Images President Donald Trump on Thursday struck landmark deals with Eli Lilly and Novo Nordisk that could mark a turning point in how many people can access […]

Read More
Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows 
Health

Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows 

The Omada Health logo is displayed on a smartphone screen. Sopa Images | Lightrocket | Getty Images Virtual care company Omada Health on Thursday said it will start prescribing GLP-1s and other obesity drugs and helping patients manage those medications. Omada plans to expand the offerings under its weight management program as its membership grows […]

Read More
Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage
Health

Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage

U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025. Jonathan Ernst | Reuters President Donald Trump on Thursday announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, including upcoming […]

Read More